| 1 |
The role of viruses in cancer development versus cancer therapy: An oncological perspective |
|
|
| Hossein Javid, Alireza Sharbaf Mashhad, Shaghayegh Yazdani, Mahsa Akbari Oryani, Sanaz Akbari, Nastaran Rezagholinejad, Mahboubeh Tajaldini, Mehdi Karimi-Shahri |
|
| Cancer Medicine. 2023; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Epigenetics and immune cells in medulloblastoma |
|
|
| Francesca Gorini, Marco Miceli, Pasqualino de Antonellis, Stefano Amente, Massimo Zollo, Veronica Ferrucci |
|
| Frontiers in Genetics. 2023; 14 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
The First-In-Class Anti-AXL×CD3e Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas |
|
|
| Nicoletta Polerŕ, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Craig A. Hokanson, Francesco Conforti, Nicoletta Staropoli, Luigia Gervasi, Maria Teresa Di Martino, Mariamena Arbitrio, Giuseppe Nisticň, Roberto Crea, Pierosandro Tagliaferri, Giada Juli, Pierfrancesco Tassone |
|
| Cancers. 2023; 15(6): 1647 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Anticancer effects of the HDAC inhibitor, 3ß,6ß-dihydroxyurs-12-en-27-oic acid, in MCF-7 breast cancer cells via the inhibition of Akt/mTOR pathways |
|
|
| Jong Lim, So Kyung, Yukyoung Jeon, In Kim, Jong Kwak, Hyung Kim |
|
| Oncology Reports. 2023; 49(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention |
|
|
| Rahma K. Alseksek, Wafaa S. Ramadan, Ekram Saleh, Raafat El-Awady |
|
| International Journal of Molecular Sciences. 2022; 23(15): 8141 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas |
|
|
| Zachary Braunstein, Miguel Ruiz, Walter Hanel, Polina Shindiapina, John C. Reneau, Jonathan E. Brammer |
|
| Journal of Personalized Medicine. 2022; 12(6): 964 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Clinical Implications of Necroptosis Genes Expression for Cancer Immunity and Prognosis: A Pan-Cancer Analysis |
|
|
| Xin-yu Li, Li-xin Su, Wen-Xue Chen, Hui Liu, Lu-yu Zhang, Yu-Chen Shen, Jian-Xiong You, Jing-Bing Wang, Liming Zhang, Deming Wang, Ming-Zhe Wen, Zhenfeng Wang, Yu-hao Shao, De-Hu Chen, Xi-tao Yang |
|
| Frontiers in Immunology. 2022; 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer |
|
|
| Siddhartha Das Pramanik, Amit Kumar Halder, Ushmita Mukherjee, Dharmendra Kumar, Yadu Nandan Dey, Mogana R |
|
| Frontiers in Chemistry. 2022; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
DNTTIP1 is a Prognostic Biomarker Correlated With Immune Infiltrates in Hepatocellular Carcinoma: A Study Based on The Cancer Genome Atlas Data |
|
|
| Changyu Zhu, Rongsheng Tong, Xiaolei Jiang, Hua Xiao, Jianmei Guan, Jianchen Shu |
|
| Frontiers in Genetics. 2022; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Potential of histone deacetylase inhibitors for the therapy of ovarian cancer |
|
|
| Fengyi Guo, Hongjing Wang |
|
| Frontiers in Oncology. 2022; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Review: Neurological Complications From Therapies for Pediatric Brain Tumors |
|
|
| Thien Nguyen, Sabine Mueller, Fatema Malbari |
|
| Frontiers in Oncology. 2022; 12 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer |
|
|
| Garyfallia Pantelaiou-Prokaki, Iga Mieczkowska, Geske E. Schmidt, Sonja Fritzsche, Evangelos Prokakis, Julia Gallwas, Florian Wegwitz |
|
| Clinical Epigenetics. 2022; 14(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Repression of the PRELP gene is relieved by histone deacetylase inhibitors through acetylation of histone H2B lysine 5 in bladder cancer |
|
|
| Kanto Shozu, Syuzo Kaneko, Norio Shinkai, Ai Dozen, Hirofumi Kosuge, Makoto Nakakido, Hidenori Machino, Ken Takasawa, Ken Asada, Masaaki Komatsu, Kouhei Tsumoto, Shin-Ichi Ohnuma, Ryuji Hamamoto |
|
| Clinical Epigenetics. 2022; 14(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Selective Inhibitors of Histone Deacetylase 10 (HDAC-10) |
|
|
| Eftiola Pojani, Daniela Barlocco |
|
| Current Medicinal Chemistry. 2022; 29(13): 2306 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Histone deacetylase 4 and 5 translocation elicited by microsecond pulsed electric field exposure is mediated by kinase activity |
|
|
| Zahra Safaei, Gary L. Thompson |
|
| Frontiers in Bioengineering and Biotechnology. 2022; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents |
|
|
| Isil Nihan Korkmaz, Hasan Özdemir |
|
| Applied Biochemistry and Biotechnology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells |
|
|
| Elisabetta Di Bello, Veronica Sian, Giulio Bontempi, Clemens Zwergel, Rossella Fioravanti, Beatrice Noce, Carola Castiello, Stefano Tomassi, Davide Corinti, Daniela Passeri, Roberto Pellicciari, Ciro Mercurio, Mario Varasi, Lucia Altucci, Marco Tripodi, Raffaele Strippoli, Angela Nebbioso, Sergio Valente, Antonello Mai |
|
| European Journal of Medicinal Chemistry. 2022; : 115022 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
KDM1A/LSD1 as a promising target in various diseases treatment by regulating autophagy network |
|
|
| Ting Ma, Anqi Li, Yueyang Guo, Shaotong Li, Meng Li, Siqi Feng, Hongmin Liu |
|
| Biomedicine & Pharmacotherapy. 2022; 148: 112762 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma |
|
|
| Shiyang Zhai,Huimin Zhang,Rui Chen,Jiangxia Wu,Daiqiao Ai,Shunming Tao,Yike Cai,Ji-Quan Zhang,Ling Wang |
|
| European Journal of Medicinal Chemistry. 2021; : 113824 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 20 |
A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma |
|
|
| Stephen W. Booth,Toby A. Eyre,John Whittaker,Leticia Campo,Lai Mun Wang,Elizabeth Soilleux,Daniel Royston,Gabrielle Rees,Murali Kesavan,Catherine Hildyard,Farasat Kazmi,Nick La Thangue,David Kerr,Mark R. Middleton,Graham P. Collins |
|
| BMC Cancer. 2021; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 21 |
How can exposure to engineered nanomaterials influence our epigenetic code? A review of the mechanisms and molecular targets |
|
|
| Luciana Moreira,Carla Costa,Joana Pires,Joăo Paulo Teixeira,Sónia Fraga |
|
| Mutation Research/Reviews in Mutation Research. 2021; 788: 108385 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 22 |
Mitochondrial Proteins in Heart Failure: The Role of Deacetylation by SIRT3 |
|
|
| Chunfang Wang,Yating Wang,Li Shen |
|
| Pharmacological Research. 2021; : 105802 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 23 |
Molecular mechanisms underpinning sarcomas and implications for current and future therapy |
|
|
| Victoria Damerell,Michael S. Pepper,Sharon Prince |
|
| Signal Transduction and Targeted Therapy. 2021; 6(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 24 |
Characterizing binding intensity and energetic features of histone deacetylase inhibitor pracinostat towards class I HDAC isozymes through futuristic drug designing strategy |
|
|
| Shabir Ahmad Ganai |
|
| In Silico Pharmacology. 2021; 9(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 25 |
Targeting the signal pathways triggered by cyclic peptides: A potential therapeutic strategy for alleviation of cancer |
|
|
| Yiyuan Yang,Hui Mao,Linxi Chen,Lanfang Li |
|
| Archives of Biochemistry and Biophysics. 2021; : 108776 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 26 |
Epigenetic Enzymes: A Role in Aging and Prospects for Pharmacological Targeting |
|
|
| Elena G. Pasyukova,Alexander V. Symonenko,Olga Y. Rybina,Alexander M. Vaiserman |
|
| Ageing Research Reviews. 2021; : 101312 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 27 |
Regulation of SIRT2 by Wnt/ß-catenin signaling pathway in colorectal cancer cells |
|
|
| Chang Li,Yuning Zhou,Ji Tae Kim,Tomoko Sengoku,Michael C. Alstott,Heidi L. Weiss,Qingding Wang,B. Mark Evers |
|
| Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2021; 1868(4): 118966 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 28 |
Histone Deacetylase Sirtuin 1 Promotes Loss of Primary Cilia in Cholangiocarcinoma |
|
|
| Kishor Pant,Estanislao Peixoto,Seth Richard,Aalekhya Biswas,M. Gerard O’Sullivan,Nasra Giama,Yeonjung Ha,Jun Yin,Pietro Carotenuto,Massimiliano Salati,Yanan Ren,Rendong Yang,Brunella Franco,Lewis R. Roberts,Sergio A. Gradilone |
|
| Hepatology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 29 |
Quisinostat mediated autophagy is associated with differentiation in neuroblastoma SK-N-SH cells |
|
|
| Vamsi Krishna Kommalapati,Dinesh Kumar,Anjana Devi Tangutur |
|
| Molecular Biology Reports. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 30 |
Post-translational lysine ac(et)ylation in health, ageing and disease |
|
|
| Anna-Theresa Blasl,Sabrina Schulze,Chuan Qin,Leonie G. Graf,Robert Vogt,Michael Lammers |
|
| Biological Chemistry. 2021; 0(0) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 31 |
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives |
|
|
| Robert Jenke,Nina Reßing,Finn K. Hansen,Achim Aigner,Thomas Büch |
|
| Cancers. 2021; 13(4): 634 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 32 |
Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives |
|
|
| Annalisa Chianese,Biagio Santella,Annalisa Ambrosino,Debora Stelitano,Luca Rinaldi,Massimiliano Galdiero,Carla Zannella,Gianluigi Franci |
|
| Cancers. 2021; 13(11): 2761 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 33 |
A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer |
|
|
| Qipeng Fan,Lihong Li,Tian-Li Wang,Robert E. Emerson,Yan Xu |
|
| Cancers. 2021; 13(15): 3821 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 34 |
Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins |
|
|
| Juan Zhang,Xuefeng Gao,Li Yu |
|
| Frontiers in Oncology. 2021; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 35 |
Role of HDAC6 and Its Selective Inhibitors in Gastrointestinal Cancer |
|
|
| Bingyi Zhou, Deliang Liu, Yuyong Tan |
|
| Frontiers in Cell and Developmental Biology. 2021; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 36 |
8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1 |
|
|
| Qiting Zhang,Ziyan Wang,Xinyuan Chen,Haoxiang Qiu,Yifan Gu,Ning Wang,Tao Wang,Ze Wang,Huabin Ma,Yufen Zhao,Bin Zhang |
|
| International Journal of Molecular Sciences. 2021; 22(11): 5516 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 37 |
Las propiedades epigenéticas y anticáncer del ácido valproico |
|
|
| Ismael Vásquez-Moctezuma,Estefanía Fernández-Navarrete,Gabriela Rebeca Luna-Palencia |
|
| Revista Mexicana de Mastología. 2020; 10(2): 54 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 38 |
Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma |
|
|
| Kishor Pant,Estanislao Peixoto,Seth Richard,Sergio A. Gradilone |
|
| Cells. 2020; 9(3): 780 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 39 |
Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro |
|
|
| Saira Justin,Jochen Rutz,Sebastian Maxeiner,Felix K.-H. Chun,Eva Juengel,Roman A. Blaheta |
|
| International Journal of Molecular Sciences. 2020; 21(15): 5582 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 40 |
A Toxicity Prediction Tool for Potential Agonist/Antagonist Activities in Molecular Initiating Events Based on Chemical Structures |
|
|
| Kota Kurosaki,Raymond Wu,Yoshihiro Uesawa |
|
| International Journal of Molecular Sciences. 2020; 21(21): 7853 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 41 |
Epigenetic Research in Stem Cell Bioengineering—Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials |
|
|
| Claudia Dompe,Krzysztof Janowicz,Greg Hutchings,Lisa Moncrieff,Maurycy Jankowski,Mariusz J. Nawrocki,Malgorzata Józkowiak,Paul Mozdziak,Jim Petitte,Jamil A. Shibli,Marta Dyszkiewicz-Konwinska,Malgorzata Bruska,Hanna Piotrowska-Kempisty,Bartosz Kempisty,Michal Nowicki |
|
| Cancers. 2020; 12(4): 1016 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 42 |
Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents |
|
|
| Loredana Cappellacci,Diego R. Perinelli,Filippo Maggi,Mario Grifantini,Riccardo Petrelli |
|
| Current Medicinal Chemistry. 2020; 27(15): 2449 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 43 |
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential |
|
|
| Alexandre Perla,Lívia Fratini,Paula S. Cardoso,Carolina Nör,André T. Brunetto,Algemir L. Brunetto,Caroline Brunetto de Farias,Mariane Jaeger,Rafael Roesler |
|
| Frontiers in Cell and Developmental Biology. 2020; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 44 |
Recent Update of HDAC Inhibitors in Lymphoma |
|
|
| I-Chung Chen,Bidyadhar Sethy,Jing-Ping Liou |
|
| Frontiers in Cell and Developmental Biology. 2020; 8 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 45 |
Construction prognosis model based on autophagy-related gene signatures in hepatocellular carcinoma |
|
|
| Jiangtao Wang,Yandong Miao,Juntao Ran,Yuan Yang,Quanlin Guan,Denghai Mi |
|
| Biomarkers in Medicine. 2020; 14(13): 1229 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 46 |
A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells |
|
|
| Bailin He,Qiang Wang,Xiaoli Liu,Ziyuan Lu,Jiaochan Han,Chengyun Pan,Bing Z. Carter,Qifa Liu,Na Xu,Hongsheng Zhou |
|
| Biomedicine & Pharmacotherapy. 2020; 129: 110390 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 47 |
Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells |
|
|
| Mona Dawood,Mohamed Elbadawi,Madeleine Böckers,Gerhard Bringmann,Thomas Efferth |
|
| Biomedicine & Pharmacotherapy. 2020; 129: 110454 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 48 |
Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury |
|
|
| Wei Zhang,Yinjie Guan,George Bayliss,Shougang Zhuang |
|
| American Journal of Physiology-Renal Physiology. 2020; 319(6): F1015 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 49 |
Genome-wide identification and transcriptional modulation of histone variants and modification related genes in the low pH-exposed marine rotifer Brachionus koreanus |
|
|
| Young Hwan Lee,Min-Sub Kim,Haksoo Jeong,Atsushi Hagiwara,Jae-Seong Lee |
|
| Comparative Biochemistry and Physiology Part D: Genomics and Proteomics. 2020; 36: 100748 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 50 |
Gelated vorinostat with inner-lysosome triggered release for tumor-targeting chemotherapy |
|
|
| Changyong Guo,Qirong Wang,Xingjie Zhang,Fengkun Lu,Miao Sun,Peiyu Zeng,Linhong Sun,Lan She,Bingkai Wang,Yunchang Zhang,Chen Wang,Zhiqiang Ma,Feng Yang |
|
| Colloids and Surfaces B: Biointerfaces. 2020; : 111144 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 51 |
The Development Process: from SAHA to Hydroxamate HDAC Inhibitors with Branched CAP Region and Linear Linker |
|
|
| Feifei Yang,Na Zhao,Yunjie Hu,Cheng-Shi Jiang,Hua Zhang |
|
| Chemistry & Biodiversity. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 52 |
Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes |
|
|
| Paul Peixoto,Céline Grandvallet,Jean-Paul Feugeas,Michaël Guittaut,Eric Hervouet |
|
| Cells. 2019; 8(12): 1656 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
